| [1] |
MACK CL, ADAMS D, ASSIS DN, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases[J]. Hepatology, 2020, 72(2): 671-722. DOI: 10.1002/hep.31065. |
| [2] |
YUAN X, DUAN SZ, CAO J, et al. Noninvasive inflammatory markers for assessing liver fibrosis stage in autoimmune hepatitis patients[J]. Eur J Gastroenterol Hepatol, 2019, 31(11): 1467-1474. DOI: 10.1097/MEG.0000000000001437. |
| [3] |
GATSELIS NK, ZACHOU K, KOUKOULIS GK, et al. Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics[J]. World J Gastroenterol, 2015, 21(1): 60-83. DOI: 10.3748/wjg.v21.i1.60. |
| [4] |
SEBODE M, WEILER-NORMANN C, LIWINSKI T, et al. Autoantibodies in autoimmune liver disease-clinical and diagnostic relevance[J]. Front Immunol, 2018, 9: 609. DOI: 10.3389/fimmu.2018.00609. |
| [5] |
KATSUMI T, UENO Y. Epidemiology and surveillance of autoimmune hepatitis in Asia[J]. Liver Int, 2022, 42(9): 2015-2022. DOI: 10.1111/liv.15155. |
| [6] |
CAPRA AP, CHIARA E, BRIUGLIA S. Autoimmune hepatitis in genetic syndromes: A literature review[J]. World J Hepatol, 2021, 13(10): 1328-1340. DOI: 10.4254/wjh.v13.i10.1328. |
| [7] |
GUO L, ZHOU L, ZHANG N, et al. Extrahepatic autoimmune diseases in patients with autoimmune liver diseases: a phenomenon neglected by gastroenterologists[J]. Gastroenterol Res Pract, 2017, 2017: 2376231. DOI: 10.1155/2017/2376231. |
| [8] |
MANNS MP, LOHSE AW, VERGANI D. Autoimmune hepatitis-Update 2015[J]. J Hepatol, 2015, 62(1 Suppl): S100-S111. DOI: 10.1016/j.jhep.2015.03.005. |
| [9] |
SIRBE C, SIMU G, SZABO I, et al. Pathogenesis of autoimmune hepatitis- cellular and molecular mechanisms[J]. Int J Mol Sci, 2021, 22(24): 13578. DOI: 10.3390/ijms222413578. |
| [10] |
VENTO S, GUELLA L, MIRANDOLA F, et al. Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals[J]. Lancet, 1995, 346(8975): 608-609. DOI: 10.1016/s0140-6736(95)91438-2. |
| [11] |
European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Autoimmune hepatitis[J]. J Hepatol, 2015, 63(4): 971-1004. DOI: 10.1016/j.jhep.2015.06.030. |
| [12] |
Chinese Society of Hepatology, Chinese Medical Association. Guidelines on the diagnosis and management of autoimmune hepatitis (2021)[J]. J Clin Hepatol, 2022, 38(1): 42-49. DOI: 10.3760/cma.j.cn112138-20211112-00796 |
| [13] |
BINICIER OB, GVNAY S. The efficacy and adverse effects of budesonide in remission induction treatment of autoimmune hepatitis: a retrospective study[J]. Croat Med J, 2019, 60(4): 345-351. DOI: 10.3325/cmj.2019.60.345. |
DownLoad:
